Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Narcolepsy with cataplexy.

Yves Dauvilliers1, Isabelle Arnulf, Emmanuel Mignot

  • 1Neurologie, CHU Montpellier Hôpital Gui-de-Chauliac and INSERM U888, Montpellier-France. ydauvilliers@yahoo.fr

Lancet (London, England)
|February 13, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Redefining hypersomnia disorders in the context of psychiatry.

L'Encephale·2026
Same author

To diagnose Narcolepsy type 1 after a negative Multiple Sleep Latency Test: the contribution of systematic hypocretin measurement.

Sleep·2026
Same author

A Two-Stage Questionnaire and Actigraphy Screening for iRBD in a Multicenter Retrospective Cohort.

Annals of clinical and translational neurology·2026
Same author

The Brain Imaging and Neurophysiology Dataset of large-scale multimodal neural data.

Scientific data·2026
Same author

Ancestry-specific and multi-ancestry genome-wide association studies of restless legs syndrome.

medRxiv : the preprint server for health sciences·2026
Same author

Machine and deep learning in REM sleep behavior disorder: a scoping review and analysis of reporting quality.

Sleep medicine reviews·2026
Same journal

Convergence of metabolic risk in obesity and normal BMI: does risk disappear?

Lancet (London, England)·2026
Same journal

Metabolic traits in obesity and normal BMI in industrialised countries: a multi-country analysis of national population-based studies.

Lancet (London, England)·2026
Same journal

Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

Lancet (London, England)·2026
Same journal

The US Ebola response and the future of global health leadership.

Lancet (London, England)·2026
Same journal

Daniel Mason: a tale of change.

Lancet (London, England)·2026
Same journal

The 2026 Wakley-Wu Lien Teh Prize Essay: why medicine, and why stay?

Lancet (London, England)·2026
See all related articles

Narcolepsy with cataplexy is a rare neurological disorder characterized by excessive daytime sleepiness and muscle weakness. Early recognition by healthcare providers is crucial for timely diagnosis and management of this lifelong condition.

Area of Science:

  • Neurology
  • Sleep Medicine
  • Immunogenetics

Background:

  • Narcolepsy with cataplexy is a rare, disabling sleep disorder affecting 0.02% of adults globally.
  • Key symptoms include severe daytime sleepiness, sudden muscle tone loss (cataplexy), sleep paralysis, hallucinations, and disrupted nighttime sleep.
  • The disorder typically emerges in adolescence or young adulthood and is a lifelong condition.

Purpose of the Study:

  • To summarize the clinical characteristics, pathophysiology, and management of narcolepsy with cataplexy.
  • To highlight the importance of early identification by primary healthcare providers.

Main Methods:

  • Review of pathophysiological studies on narcolepsy with cataplexy.
  • Analysis of clinical presentation and diagnostic findings, including sleep monitoring.

Related Experiment Videos

  • Examination of genetic predispositions and treatment strategies.

    • Main Results:

    • Narcolepsy with cataplexy results from the loss of hypocretin-producing neurons in the hypothalamus.
    • The HLA DQB1*0602 allele is a significant predisposing factor, suggesting an autoimmune component.
    • Sleep studies reveal rapid sleep onset and shortened REM sleep latency.

    Conclusions:

    • Narcolepsy with cataplexy is an under-recognized disorder requiring increased awareness among healthcare professionals.
    • Effective treatments include stimulants for sleepiness, antidepressants for cataplexy, and gamma hydroxybutyrate.
    • Early diagnosis and management are essential for improving patient outcomes.